Mifepristone
- Level
- Commodity
- Parent
- 51351600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51351613This classification denotes an anti-progestin with the molecular formula C29H35NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 320T6RNW1F, chemically known as 17-beta-hydroxy-11-beta-(4-dimethylaminophenyl-1)-17-alpha-(prop-1-ynyl)oestra-4,9-dien-3-one but generally known as mifepristone, which bears US NIH Compound Identifier 55245. European Medicines Agency schedules Mifepristone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08956MIG. The term MIFEPRISTONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). World Health Organization schedules mifepristone in its Anatomical Therapeutic Chemical (ATC) Classification. MIFEPRISTONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule mifepristone under HS 29372900 and SITC 54153. As of Q4 2014, MIFEPRISTONE remains the US FDA Preferred Term for this commodity. Mifepristone bears US NLM identifiers UMLS ID C0026088 and NCI Concept Code C655. SMILES: OC1(C2(C(C3C(=C4C(=CC(=O)CC4)CC3)C(C2)c2ccc(N(C)C)cc2)CC1)C)C#CC.
Same parent
Under 51351600 · 35Activities that produce or sell this
KBLI · 8Inherited from family 51350000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.